RESEARCH & INNOVATION

Allan Collins, MD, FACP, and Eric Weinhandl, PhD, outline how more frequent home hemodialysis can ultimately can improve cardiac structure.

Learn about our global commitment to improving the lives of kidney disease patients through interconnected intelligence.

Increased knowledge of how salt is stored in the skin is changing the view on how to measure and treat salt in kidney patients. Peter Kotanko shares the latest.

Read about advancing interoperability to reduce provider burden and improve care for chronic kidney disease patients.

Improving fluid management is key to reducing patient deaths from cardiovascular causes. Learn about two new innovations from FMC in fluid management.

Learn about advacements using hypoxia-inducible factors (HIFs) for managing anemia in patients with chronic kidney disease (CKD). Read more.

Read how FMCNA data scientists converted sound into non-discernible numerical data that can potentially be used to classify clinic-level quality outcomes.

Learn about opportunities presented from integrating medically tailored meals into kidney disease treatment programs.

Experts share how improving vascular access and reducing catheter contact time can improve patient's lives and save the healthcare system millions of dollars.

The NIH provided 10 times more funding for cancer than kidney disease even though more people are diagnosed with kidney disease. Kurt Mussina explains why.

FMCNA's Emergency Preparedness Checklist will help administrators develop a plan to address the unique demands of kidney treatment. Download for free!

Fresenius Kidney Care Achieves 5-Diamond Status in its Dialysis Centers.

The inaugural interview for the new Global Medical Office Dialogues video series is with William Kaelin Jr., MD, Sydney Farber Professor at Harvard Medical School, Dana Farber, and Brigham and Women's Hospital in the United States, and winner of the 2019 Nobel Prize for his research with two others regarding how cells sense and adapt to oxygen availability with implications for anemia and chronic kidney disease care.

Dr. Ahmad Sharif, Senior Vice President and Chief Medical Information Officer at Fresenius Medical Care North America, discusses the important use of telehealth to safely treat patients during the COVID-19 era and what the future holds for virtual patient care when the pandemic ends.

Dr. Dugan Maddux, Vice President of Kidney Disease Initiatives for Fresenius Medical Care North America, joins Field Notes to discuss the consequences of food insecurity for people living with serious chronic conditions and the importance of medically tailored meals in treating kidney disease.

Len Usvyat, PhD, Vice President of Applied Advanced Analytics, joins Field Notes to explain how artificial intelligence is being used to provide better treatment for people with kidney disease by predicting potential outcomes and future health care needs.

As the COVID-19 pandemic continues, its impacts on the body continue to be understood. Dr. Ted Toffelmire, the Senior Director of Medical Affairs in Canada for Fresenius Medical Care North America, joins Field Notes to discuss a potential link between the devastating virus and acute kidney injury.

Listen to Field Notes, a podcast by FMCNA. Dr. Peter Kotanko discusses a new mathematical model for pool testing COVID-19.

Listen to Field Notes, a podcast by FMCNA. Bob Loeper joins to discuss what it takes to ensure dialysis care for patients after a major diaster.

Listen to Field Notes, a podcast by FMCNA. This episode welcomes Dr. Laura Niklason, co-founder of Humacyte, as she talks about dialysis access improvements.

Listen to Field Notes, a podcast by FMCNA. Dr. Jeffrey Hymes joins to discuss FMCNA's COVID-19 pandemic response to keeping patients safe.

Gina Sharkey and Tana Waack join Field Notes to provide a behind-the-scenes look at the front-lines inside some of the hospitals hit hardest by COVID-19.

Chance Mysayphonh, PharmD, clinical pharmacist for Fresenius Medical Care North America, joins Field Notes to discuss how new monoclonal antibody therapies will be used in Fresenius Kidney Care centers to help fight COVID-19.

Dr. Frank Maddux, Global Chief Medical Officer, joins Field Notes to explain how a new initiative to build the world"™s largest renal-focused genomic registry will impact the future of kidney care for years to come.

Dr. Michael Anger, Chief Medical Officer of the Renal Therapies Group, joins Field Notes to discuss the methods used to prevent bone damage, preventing the need for additional and expensive therapies for patients.

Originally developed to treat diabetes, SGLT2 inhibitors are potentially groundbreaking in slowing the progression of chronic kidney disease (CKD).

Joe Turk, former president of NxStage Medical and current president of home and critical care therapies for FMCNA, joins Field Notes to discuss how the merger is helping evolve and grow technology for home dialysis and critical care.

Laura Kemper and Nate Elias discuss how Fresenius Medical Care procured and distributed COVID vaccines to ESRD patients in dialysis centers nationwide.

Dr. David Thompson discusses heart and lung support with a new, FDA approved, ECMO machine called Novalung from FMCNA.

Dr. Kam Kalantar, an expert in kidney diseases and epidemiology, joins Field Notes to help us better understand the importance of managing albumin levels.

Ines Dahne-Steuber, president of Spectra laboratories and Dr. Alex Ryder, Spectra's medical director discuss the opening of its new Mississippi Lab.

Dr. Jeffrey Hymes explains why COVID-19 boosters are necessary and safe, and why they are so effective to protecting our patients with Kidney Disease.

Dr. Shelly Nash joins Field Notes to answer questions on what telehealth could look like in a post COVID-19 world.

Dr. Michael Anger and Jeffrey Carr discuss the significant impact of linking genomic and clinical data of both CKD and ESRD participants to improve outcomes.

Dr. Murat Sor joins Field Notes to discuss how optimal starts can result in fewer complications, reduce costs, and improve outcomes for patients.

FreseniusRx is expanding its services beyond just kidney care to include non-renal medications and will become a go-to pharmacy for our patients’ medications needs. Senior Director of Pharmacy Michelle Nguyen, PharmD explains how this will work and why it is so important to ensure successful medical management and adherence.

Dr. Stefano Stuard and Dr. Volodymyr Novakivskyy join this episode to talk about how they prepared patients in Ukraine prior to the Russian invasion in February of 2022 and all the measures they have taken since then to provide life-saving care and accommodations for patients.

Dr. Charles Herzog and Dr. Christopher Chan join this episode of Field Notes to talk about the American Heart Association's recent statement explaining how home dialysis can improve a patient's cardiovascular health and how prescribing dialysis with heart health in mind can increase the chances for successful care plans for patients.

Dr. Michael Kraus discusses artificial intelligence and machine learning with Dr. Len Usvyat and Dr. Luca Neri.

Diversity expert and author, Lenora Billings-Harris, talks with Dr. Frank Maddux about racism and unintended bias in healthcare.

Translating Science into medicine episode one with Dr. Peter Kotanko, Reserach Director of RRI (The Renal Research Institute).

Analytics expert, Dr. Len Usvyat talks about his team's work in using advanced analytics to support clinical decision-making.

In part three of our exploration into Translating Science into Medicine, we talk with Hanjie Zhang, biostatistician at RRI, the Renal Research Institute, and an expert in artificial intelligence and machine learning.

We talk with Dr. Peter Kotanko, research director at RRI, the Renal Research Institute, about the effects of extreme climate events on vulnerable patient populations.

In this episode of Dialogues, we continue our look at Translating Science Into Medicine by talking with Dr. Doris Fuertinger, Director of Biomathematical Modeling and Simulation at Fresenius Medical Care, and a pioneer in the concept of virtual clinical trials.

Metabolomic signatures can be used to deliver more personal, precise care for patients living with kidney disease.

Investigate the relationship between human health and climate change events that can increase the risk of kidney disease and respiratory illness.

Social determinants of health such as food insecurity, have a profound impact on people living with chronic kidney disease and other related conditions.

Frenova Renal Research is building a Genomics Registry to analyze genetic sequencing data from chronic kidney disease patients worldwide. Listen now.

Combining clinical and genetic data from patients, scientists can understand how to make a more precise diagnosis of kidney disease in individualized care.

Cardiovascular disease is the number one cause of death for people with kidney disease. Learn why cardiac disease is such a problem in kidney failure patients

Improving vascular access affects outcomes for people on hemodialysis. Dr. Latif discusses improving patient outcomes by addressing opportunities in vascular access.

Real-world evidence can complement existing research in gaining new and valuable insights that improve kidney disease care with Dr. Ficociello and Dr. Winter.

Fresenius Medical Care developed its own ultrafiltration controller for fluid management. Dr. Lemuel Rivera Fuentes discusses this breakthrough innovation.

Race is currently one factor used in GFR equations. Nephrologist Nwamaka Eneanya wonders if its inclusion may contribute to systemic racism in medicine.

Dr. Nilufar Mohebbi, discusses treating metabolic acidosis in patients, which can delay the progression of chronic kidney disease.

Nephrologist Kolitha Basnayake discusses how quality improvement programs must address barriers to shared hemodialysis care for the individual.

Dr. Michael Anger joins this episode to discuss how SGLT-2 inhibitors can be used earlier with kidney disease patients and improve overall patient health.

Krister Cromm, FMCNA's Director of Patient Experience, discusses improving patient health by including patient reported outcomes in clinical trials.

Dr. Kirsten Johansen discusses the racial and ethnic disparities in CKD, ESRD, and the access to treatment of these conditions according to the USRDS.

Dr. Maria Mercedes Resk, Medical Director for Fresenius Medical Care CARICAM, discusses cardioprotection and personalizing kidney replacement therapy.

Dr. Miriam Huntley talks about improving infectious disease diagnosis and treatment, genomic sequencing, and machine learning to solve antibiotic resistance.

Dr. Len Usvyat, the Global Medical Office’s head of Clinical Advanced Analytics, talks about how real-world data generated by devices is used to improve the care of people living with kidney disease.

Dr. Laura Niklason, Founder and CEO of Humacyte, discusses this promising technology and its recent deployment as humanitarian aid for repairing vascular trauma in Ukraine.

Learn how documenting patient care, allows participating providers to improve patient outcomes through care coordination.

Get insight into how the COVID-19 pandemic continues to evolve, our understanding of disease transmission, long-term complications, and immune response.

With the high demand for testing during the covid-19 pandemic, simulation pool testing was used to identify patients with the coronavirus disease 2019.

Learn about FMCNA's global master plan to address the COVID-19 pandemic at the global, regional, and local levels.

Learn how our Fresenius Kidney Care Asia Pacific team takes a comprehensive approach to serving kidney disease patients in nearly 50 countries.

Learn how advanced analytics are used to collaborate and prioritize tools that can be meaningfully integrated into a clinician’s workflow.

Discover a new renal-focused genomic registry that will encourage more research in the underlying mechanisms of kidney disease and personalized medicine.

The NephroCare network includes more than 790 clinics and is coordinated by 28 dedicated physicians across 29 countries that make up the EMEA region.

As Fresenius Medical Care develops IT platforms, one of the biggest challenges is to balance global solutions with the need to accommodate diverse environments.

Product lifecycle management (PLM) for medical products is more complex. Learn about Fresenius Medical Care's PLM across the world.

Learn more about the Clinical Evidence Generation (CEG) research initiative and how it's focused on researching a product's real-world clinical value.

Learn how Fresenius Medical Care is reducing hurdles to transplantation and reducing kidney transplant waitlist time.

Learn how researchers at the Renal Research Institute created a mobile application that helps to identify and classify high-risk aneurysms.

FMCNA aims to improve cardioprotection during dialysis through more personalized treatment. Read more.

Tune into this episode of Field Notes to listen to Dr. Michael Kraus and Michelle Carver, Senior Vice President of Nursing and Clinical Services at Fresenius Kidney Care, discuss what we can do to improve CAPD Culture in the United States.

Dr. Reshma Kewalramani, CEO of Vertex Pharmaceuticals discusses the company’s research into the underlying cause of APOL1-mediated kidney disease.

Learn how we took the lead in developing strategies to protect patients, families, caregivers, and clinical staff from COVID-19.

During the COVID-19 pandemic, we deployed our Disaster Relief Team and created a pool of dialysis equipment to meet the increased demand of acute kidney injury patients.

As several different COVID-19 vaccines are authorized for emergency use and/or approved around the world, the race to contain the pandemic has been given a new weapon.

While current COVID-19 vaccines are very effective, manufacturers are developing strategies to ensure that new vaccines can keep pace with the rapid rate of mutation.

While global COVID-19 data confirms that dialysis patients experienced a high rate of hospitalization and death, there has been insufficient research into many issues surrounding individuals with end stage kidney disease.

The Centers for Medicare and Medicaid Services (CMS) established the end stage renal disease Prospective Payment System (PPS) to facilitate beneficiary access to renal dialysis equipment.

Our connected health platforms empower patients and clinical staff through a digital ecosystem that connects patients with healthcare professionals, medical devices, and customer service.

We are driving innovation and transformation in kidney care with research into regenerative medicine, organ transplant, and organ recovery.

Our Global Medical Office has created an interdisciplinary critical care team to help develop new critical care delivery improvements.

Our Global Medical Office has started a program to understand regional factors affecting performance in improving care for people with end stage kidney disease.

We're taking a multifaceted approach to advancing transplantation including technologies to expand the pool of kidneys available for transplant.

Patients who are active partners in their care report better physiological and psychological outcomes compared to those in more traditional dialysis care settings.

Starting dialysis in a planned way with a permanent access results in better early dialysis outcomes, improved quality of life, and lower healthcare costs.

The digital health era now offers tools for transforming clinical research through improved efficiencies of highly complex trials.

Precision medicine requires properly recognizing the right patient, having the right drugs, and knowing the right time to apply them.

By creating genomic and phenotype data sets for more than 100,000 patients, researchers can begin to unlock the complexities of CKD.

The risk of cardiovascular disease increases with the progression of CKD, so cardiovascular health is an essential component of CKD management.

We developed an ultrafiltration (UF) control algorithm to attain favorable relative blood volume (RBV) ranges by comparing the RBV profile to the target curve and making UF adjustments.

The ability to take healthcare innovations and learnings from one locale to another has helped us make an impact in communities worldwide.

Cardiac disease prevention and management is one of the most important clinical targets in patients receiving maintenance dialysis.

We are devoted to providing precise and personalized care while improving vascular access for people on hemodialysis.

In this 48th episode of Field Notes, Dr. Michael Kraus discusses artificial intelligence and machine learning with Dr. Luca Neri and Caitlin Monaghan. This is a two part-series, with the first part covering artificial intelligence more generally and this second part diving deeper into artificial intelligence in medicine and nephrology.

Hemodialysis patients who skipped the influenza vaccine were significantly more likely to be hospitalized than those who were vaccinated, suggests a three-year study of more than 150,000 kidney dialysis patients being presented today in Chicago at 2016 Kidney Week, the annual meeting of the American Society of Nephrology (ASN).

Dragonflies can see everything, all the time, all around. They have so many lenses on their head that nothing gets by them. When they see a predator approach, they can react in a fraction of a second. I wish I had the eyes of a dragonfly.

Dr. Frank Maddux discusses how HUMACYL® could potentially improve vascular access options for hemodialysis patients.

A discussion with Jeffrey L. Hymes, MD, Chief Medical Officer for Fresenius Kidney Care, on the ways connected health technologies enhance patient care.

Read about 5 end stage renal disease innovations helping transform the lives of kidney patients.

Researchers discover 35 kidney genes that predispose people to chronic kidney disease. Read more.

FMC researchers found that ESRD patients who skipped the flu shot have an increased chance of hopilization. Learn more.

Reasearch shows chronic kidney disease impacts men and women differently. Learn why more women are diagnonsed with CKD and more, here.

Fresenius Medical Care shares how missing a dialysis treatment was not an option for patients at one Fresenius Kidney Care clinic in Louisberg, North Carolina.

An interview with Tammie Kear, Ph.D., R.N., CNN, Fresenius Medical Care nurse and President-elect of the American Nephrology Nurses Association.

Discover how Fresenius Kidney Care developed a program using a new hep C treatment, Zepatier, to help cure dialysis patients of hepatitis C.

Fresenius speaks with Kurt Mussina, GM of Frenova Renal Research on how providers can overcome the barriers to enrolling renal patients in clinical trials.

An interview with Len Usvyat about the increasing importance of artificial intelligence to deliver new insights that improve outcomes for our patients.

A preliminary analysis of new data from more than 9,000 patients with acute kidney injury receiving outpatient dialysis provides important insights.

A newly released annual study from the American Heart Association shows the prevalence of heart disease is higher due to new guidelines for high blood pressure.

Donnie King, a renal patient who attends dialysis three times a week at Fresenius Kidney Care in Mississippi, discusses the benefits he receives from participating in clinical trials with Frenova Renal Research. Donnie says his experience has been rewarding and that "It's a great way to give back and make a difference."

Find out why home dialysis is ready to take off in the U.S. and become the modality of choice for 25 percent of patients with kidney failure by 2022

Mark Costanzo, President of Fresenius Medical Care North America’s Renal Therapies Group, discusses how the company’s expertise in treating kidney failure is supporting the development of new treatments for acute lung failure as well.

In an unexpected discovery, researchers recently determined that a medication commonly used to treat Type 2 diabetes also slows the progression of chronic kidney disease (CKD), significantly reducing the risk of developing kidney failure or end stage kidney disease.

Fresenius Medical Care North America celebrates Earth Day 2019 by sharing the ways the many parts of life-sustaining dialysis machines are reused and recycled.

A study shows that exposure to other people’s tobacco exhalations can also increase a person’s risk of chronic kidney disease (CKD) and kidney failure.

A discussion about phosphate binders with Dr. Robert Kossmann, Chief Medical Officer for Fresenius Medical Care North America (FMCNA), including new research being presented at the 2019 National Kidney Foundation (NKF) Spring Clinical Meetings in Boston.

Researchers discovered a new compound that restores kidney function, unlocking opportunities to treat kidney disease progression.

There is mounting evidence that COVID-19 not only damages the lungs, but also the kidneys resulting in emergency dialysis. Read more here.

A new model by the Renal Research Institute suggests that pool testing for COVID-19 could offer some advantages. Read more.

Learn more about the Ben J. Lipps Research Fellowship, a program that supports research around kidney disease treatments.

On February 21, 2020, the U.S. Food and Drug Administration (FDA) cleared Novalung®, a heart and lung support system for the treatment of acute respiratory or cardiopulmonary failure in adults. Novalung is the first extracorporeal membrane oxygenation (ECMO) system to be cleared for more than six hours of use as extracorporeal life support.

The BioSticker is a body sensor that helps monitor patients with kidney failure and those transitioning to dialysis treatment at home. Read more here.

As a company, we strive to better the lives of our patients, employees, and the communities we serve through our commitment to the environment. As an industry leader, it is important to live our values and adopt sustainable solutions.

A new predictive tool designed specifically to identify dialysis patients most at risk for hospitalization has been embraced by nurses who have come to see it as essential.

On October 22, 2019, Donate Life America (DLA) and the Fresenius Medical Care Foundation (Foundation) announced a unique partnership, launching a groundbreaking national, universal living donor kidney registry and at home living testing kit.

In this Q&A Dr. Robert Kossmann, Chief Medical Officer for Fresenius Medical Care North America (FMCNA), discusses efforts to develop a new dialyzer and hemodialysis system that aims to prevent clotting and eliminate the need for blood thinners in most patients.

Sweltering heat and rising average temperatures around the globe are posing serious health risks for people living with kidney failure, according to a new study by researchers at the University of Maryland School of Public Health and the Renal Research Institute.

A new study provides valuable insight into the potential role genetic factors play in kidney disease.

The Renal Research Institute (RRI) is allowing immediate access through online platforms to critical new science regarding COVID-19 and its impact on kidney care.

B Positive, a new CBS sitcom, sheds light on kidney transplants and the experience for both donors and recipients.

An innovative digital screening tool is being piloted in select Fresenius Kidney Care clinics to better identify behavioral health needs of people living with kidney failure.

When dialysis emergencies arise, it is important to be prepared. After a water main break impacted Tampa, FL, the NxStage Critical Care team quickly came to the aid of one large area hospital.

Fresenius Kidney Care has started to administer a new antibody treatment specifically issued as a COVID-19 therapy for people with CKD. Read more here.

The new guidelines include 12 recommendations for patient care, as well as 48 practice points for clinicians dealing with diabetes and Chronic Kidney Disease. Read more here.

Combat physician burnout during COVID-19 with these three tips by Felicia Speed.

Last year, the U.S. Department of Health and Human Services announced the Advancing American Kidney Health Initiative to encourage home dialysis and transplant for people living with kidney failure. As the agency prepares to roll out final payment models under this new program, it will be yet another step toward a paradigm shift in kidney care.

Physicians have a choice of dialyzers when prescribing hemodialysis for CKD patients. Learn more about high flux, low flux and other types of dialyzers.

Learn why dialysate purity is important and what the benefits of ultrafiltration are.

Learn about health insurance coverage options for people with chronic kidney disease, any limitations they have, and how they impact you.

Learn more about Fresenius Medical Care dialyzers and how to choose the right dialyzer for your patients.

Nephrology can be a rewarding career path. Learn more about pursuing a career in nephrology and what it takes to provide kidney patients the best care.

Performing a Peritoneal Equilibration Test can help measure peritoneal dialysis treatment efficiency and optimize the PD prescription. Learn more about PET.

FMCNA continues to work to educate dialysis patients and employees about the importance of the COVID-19 vaccination. See how the results are paying off.

Home dialysis machines that perform in emergencies are essential for patients. NxStage machines have features to ensure continued treatment when disaster strikes.

Reducing the spread of COVID-19 by testing dialysis patient face masks, earns Renal Research Institute a KidneyX COVID-19 Kidney Care Challenge award.

Fresenius Medical Care Renal Technologies shares how technology assessments helped reduce the water and electricity used by dialysis and water purification systems.

A strong foundation in data privacy and security played a pivotal role in allowing FMCNA to continue to provide life-sustaining care to patients during COVID-19.

NxStage Critical Care expresses its heartfelt gratitude to ICU teams across the country for the heroism displayed throughout the COVID-19 pandemic

Providing clean, purified water for hemodialysis therapy is critical to driving positive patient outcomes. We talk to the experts about reverse osmosis systems.

The (FMCNA) Medical Office highlights the top 5 innovations in kidney care to watch for in 2021, potentially transforming the lives of dialysis patients.

Find out how the antibiotic stewardship program is exploring a range of strategies to optimize antibiotic administration for ESRD patients.

Acumen 2.0, developed by FMCNA in collaboration with Epic Systems, is a solution tailored to the needs of individual nephrology practices. Learn more.

Emel Hamilton and Scott Ash share how Fresenius Kidney Care is improving its 5 Star Quality Metrics and ratings.

Dr. Dugan Maddux shares how kidney supportive care is improving quality of life for ESRD patients. Read more about FMC’s dedication to patient-focused care.

Learn how healthcare consumers are connected with their health information through electronic medical records, patient portals and mobile apps.

Read more about how Fresenius Medical Care is advancing medicine using clinical trials in renal care..

Partnerships with renal pharmacies offer innovative support to multidisciplinary healthcare teams and are gaining new attention with promising outcomes.

Discover how pharmacists can take a lead role in delivering effective patient care services to improve medication adherence and optimize patient outcomes.

Renal medications are an essential component of treating and preventing secondary complications in patients with chronic kidney disease (CKD).

Revenue cycle management (RCM) is the process a healthcare provider uses to track patient service revenue from the time of account creation to the final payment.

Learn about the 4 types of healthcare analytics and how to apply them in your practice.

Learn more about ESRD Seamless Care Organizations, or ESCOs, including the anticipated advantages and eligibility requirements.

Learn about our integrated health plans and services that focus on prevention, primary care, behavioral health, and managing chronic conditions.

Learn about the top reasons to become a nephrology clinical trial investigator.

Home Hemodialysis has significant benefits as a patient-centered dialysis treatment. Learn why HHD offers improved patient outcomes and engagement.

A Q&A with Veronica Stephens, VP of Customer & Technical Services on what winning the J.D. Power award for Outstanding Customer Service means.

Kidney transplant is the ideal treatment for patients with ESRD. Learn more about what is being done to improve patient's access to kidney transplantation.

To explore alternate ways of increasing cinacalcet adherence, researchers created an innovative virtual trial. Learn more here.

In-Center Hemodialysis Consumer Assessment of Healthcare Providers and Systems (ICH CAHPS) is used to measure healthcare quality. Learn more here.

Fresenius Kidney Care conducted a study on the effectiveness of Velphoro on patients with chronic kidney disease. Read more.

Learn how regenerative medicine could be used to replace traditional hemodialysis access for ESRD patients.

Dr. Murat Sor explains the vital role percutaneous transluminal angioplasty (PTA) plays in dialysis care. Learn more.

FMCNA is creating innovative predictive models to improve patient care for dialysis and chronic kidney disease patients. Learn more.

Learn more about how FMCNA has partnered with accountable care organizations to deliver innovative value based care.

Noted researcher and scholar, Dr. Kotanko discusses how oxygen supply to vital organs could be at the heart of kidney patients' disease.

Dr. Jeffrey Hymes shares how the "Bundle" has provided a stimulus to change clinical algorithms and has enhanced dialysis patient outcomes.

Learn more about F1RST Up, Frenova Renal Research answer to addressing process enhancements and tackling other clinical trial inefficiencies.

Learn about the pivotal role caregivers play in supoorting chronic kidney disease and ESRD patients.

The Center for Disease Control (CDC) encourages people living with chronic kidney disease (CKD), to get a COVID-19 booster shot to increase antibody levels.

Learn how Fresenius Medical Care is responding to the flu season amid the ongoing COVID-19 pandemic and why receiving a flu shot is important.

Nx2me health platform has been upgraded to support video calling for hemodialysis patients. Patients can now speak directly to a nurse to resolve issues faster.

A new study from Humacyte, shows promising results using bioengineered blood vessels to bypass a blocked coronary artery, without blood vessel extraction.

Learn how FMCNA is using artificial intelligence to improve care for people on dialysis and people living with CKD and ESRD.

The benefits of Extracorporeal Membrane Oxygenation (ECMO) for patients who test positive for COVID-19, provide an alternative to mechanical ventilation.

KRT versatility can help provide for the needs of both staff and patient in emergency situation for which dialysis resources become a focal point.

In an emergency, the best KRT machines for hospital patients and staff include features essential to healthcare dialysis units. Here are 6 important features.

Recent COVID-19 experiences can serve as a guide and inspiration to help ICUs prepare for the next widespread emergency and those that will follow.

Prolonged Intermittent Kidney Replacement Therapy (PIKRT) is a hybrid dialysis treatment shown to be effective treating kidney failure patients in the ICU.

The FDA has approved Korsuva (difelikefalin) for moderate to severe pruritus associated with chronic kidney disease.

Fresenius Medical Care North America is in the ideal position to drive innovation and translate science into patient care standards. Learn more.

Dr. Isaac “Zak” Kohane, Chair of the Department of Biomedical Informatics at Harvard Medical School discusses the adoption of artificial intelligence and machine learning in healthcare.

Dr. Matthias Rose discusses the integration of patient-reported outcomes into the CONVINCE study.

In this episode of Dialogues, we continue our look at Translating Science Into Medicine by talking with Dr. Doris Fuertinger, Director of Biomathematical Modeling and Simulation at Fresenius Medical Care, and a pioneer in the concept of virtual clinical trials.

Dr. Matthias Rose discusses the integration of patient-reported outcomes into the CONVINCE study.

Metabolomic signatures can be used to deliver more personal, precise care for patients living with kidney disease.

Investigate the relationship between human health and climate change events that can increase the risk of kidney disease and respiratory illness.

Social determinants of health such as food insecurity, have a profound impact on people living with chronic kidney disease and other related conditions.

Frenova Renal Research is building a Genomics Registry to analyze genetic sequencing data from chronic kidney disease patients worldwide. Listen now.

Combining clinical and genetic data from patients, scientists can understand how to make a more precise diagnosis of kidney disease in individualized care.

Cardiovascular disease is the number one cause of death for people with kidney disease. Learn why cardiac disease is such a problem in kidney failure patients

Improving vascular access affects outcomes for people on hemodialysis. Dr. Latif discusses improving patient outcomes by addressing opportunities in vascular access.

Real-world evidence can complement existing research in gaining new and valuable insights that improve kidney disease care with Dr. Ficociello and Dr. Winter.

Fresenius Medical Care developed its own ultrafiltration controller for fluid management. Dr. Lemuel Rivera Fuentes discusses this breakthrough innovation.

Race is currently one factor used in GFR equations. Nephrologist Nwamaka Eneanya wonders if its inclusion may contribute to systemic racism in medicine.

Dr. Nilufar Mohebbi, discusses treating metabolic acidosis in patients, which can delay the progression of chronic kidney disease.

Nephrologist Kolitha Basnayake discusses how quality improvement programs must address barriers to shared hemodialysis care for the individual.

Krister Cromm, FMCNA's Director of Patient Experience, discusses improving patient health by including patient reported outcomes in clinical trials.

Dr. Michael Anger joins this episode to discuss how SGLT-2 inhibitors can be used earlier with kidney disease patients and improve overall patient health.

Dr. Kirsten Johansen discusses the racial and ethnic disparities in CKD, ESRD, and the access to treatment of these conditions according to the USRDS.

Dr. Maria Mercedes Resk, Medical Director for Fresenius Medical Care CARICAM, discusses cardioprotection and personalizing kidney replacement therapy.

Dr. Miriam Huntley talks about improving infectious disease diagnosis and treatment, genomic sequencing, and machine learning to solve antibiotic resistance.

Dr. Len Usvyat, the Global Medical Office’s head of Clinical Advanced Analytics, talks about how real-world data generated by devices is used to improve the care of people living with kidney disease.

Dr. Laura Niklason, Founder and CEO of Humacyte, discusses this promising technology and its recent deployment as humanitarian aid for repairing vascular trauma in Ukraine.

Learn how documenting patient care, allows participating providers to improve patient outcomes through care coordination.

Dr. Reshma Kewalramani, CEO of Vertex Pharmaceuticals discusses the company’s research into the underlying cause of APOL1-mediated kidney disease.

Dr. Frank Maddux discusses the potential impact of GLP-1 Rezeptor agonists and SGLT-2 Inhibitors on chronic kidney disease care.

Jochen Raimann, the director of data analytics for the Renal Research Institute, discusses the Two-Plus Study and its potential benefits for patients.

Dr. Isaac “Zak” Kohane, Chair of the Department of Biomedical Informatics at Harvard Medical School discusses the adoption of artificial intelligence and machine learning in healthcare.

David Rhew, Microsoft’s Chief Medical Officer and Vice President of Healthcare, discusses ChatGPT’s uses in healthcare.

Anjana Harve, Fresenius Medical Care’s Chief Information Office, talks about cybersecurity and the use of health information systems to improve the quality of care for patients.

Prof. Peter Blankestijn discusses the results of the multicenter CONVINCE Study including how the use of hemodiafiltration impacts patient morbidity and all-cause mortality as well as patient-reported outcomes.

Luca Neri, senior director of clinical advanced analytics at Fresenius Medical Care, discusses Anemia Management with AI and computational modeling.

Experts share why better kidney transplant access requires a vision and framework that mandates open communication and active collaboration.

In late 2018, FMCNA modeled the "tiger team" approach to look at the many issues surrounding hyperphosphatemia. Discover their results.

Read about an opportunity to evolve patient care and optimize outcomes of Medicare beneficiaries with acute kidney injury requiring dialysis (AKI-D).

Krister Cromm, Fresenius Medical Care’s Director Person-Centered Outcomes Research, discuss the company’s evolution from disease-centered to person-centered integrated trial design.

Manuela Stauss-Grabo, PhD, leads the Global Biomedical Evidence Generation Team within Fresenius Medical Care’s Global Medical Office.

Dr. Giovanni Strippoli discusses how the CONVINCE study results will contribute to reaching a higher level of certainty regarding the comparative efficacy of hemodiafiltration versus HD in people with end-stage kidney disease.

Dr. Hanjie Zhang discusses the benefits and risks of Generative AI in healthcare.

Dr. Doris Fuertinger discusses the future impact of novel therapeutic interventions on populations with kidney disease.